Exome Asset Management is an asset management firm founded in 2018 and based in New York, NY. The firm focuses on investing in the global healthcare industry, including pharmaceuticals, biopharmaceuticals, healthcare services, and medical devices. Exome Asset Management employs a strategy that includes modest leverage and both long and short positions, allowing it to invest broadly across various healthcare sub-sectors and geographies.
Notable portfolio companies include Centrexion Therapeutics, which has raised $40.5 million. Exome Asset Management’s investment philosophy centers on selecting the most innovative healthcare investments worldwide. The firm offers unique value-add services by leveraging its deep industry expertise and strategic insights to support the growth and success of its portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
